ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

CMMB Chemomab Therapeutics Ltd

0.81
0.085 (11.72%)
取引時間後
最終更新日: 05:56:50
15分遅延
名称 銘柄コード 市場 種別
Chemomab Therapeutics Ltd CMMB NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.085 11.72% 0.81 05:56:50
始値 安値 高値 終値 前日終値
0.735 0.6921 0.85 0.81 0.725
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0920:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0920:00GLOBEChemomab Therapeutics Announces First Quarter 2024 Financial..
2024/5/0820:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0820:00GLOBEChemomab Therapeutics Granted 180-Day Extension by Nasdaq to..
2024/5/0220:00GLOBEChemomab Therapeutics to Present at 2024 Aegis Virtual..
2024/4/2420:00GLOBEChemomab Therapeutics to Report First Quarter 2024 Financial..
2024/4/1820:00GLOBEChemomab Reports New Peer-Reviewed Publication Reinforcing..
2024/4/0220:00GLOBEChemomab to Host Virtual Key Opinion Leader Webinar on..
2024/3/2520:06GLOBEChemomab Awarded New European Patent for CM-101, Its..
2024/3/0721:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0721:00PRNUSChemomab Therapeutics Announces Year End and Fourth Quarter..
2024/3/0521:00PRNUSChemomab Therapeutics to Participate in Leerink Global..
2024/2/2023:20APSBiotech Shares Massively Bid Up Before Opening Bell
2024/2/2021:00PRNUSChemomab Awarded New Patents for CM-101, Its First-in Class..
2024/2/1421:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
2024/2/0521:00PRNUSChemomab Therapeutics to Participate in Upcoming Investor..
2024/1/3021:00PRNUSChemomab Therapeutics Announces New Publication Reinforcing..
2024/1/0321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0321:00PRNUSChemomab Announces Completion of Patient Enrollment in..
2023/11/1621:00PRNUSChemomab Presentation at ACR Convergence 2023 Provides..
2023/11/1606:35EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/1521:00PRNUSChemomab Therapeutics Receives FDA Fast Track Designation..
2023/11/1322:00PRNUSChemomab Presents New Clinical Data Supporting CM-101's..
2023/11/0922:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0922:00PRNUSChemomab Therapeutics Announces Third Quarter 2023 Financial..
2023/11/0706:15PRNUSChemomab Therapeutics Discloses Receipt of Nasdaq Notice..
2023/11/0614:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/10/3021:33EDGAR2Form F-3/A - Registration statement by foreign private..
2023/10/3020:00PRNUSChemomab Therapeutics to Report Third Quarter 2023 Financial..
2023/10/2620:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
2023/10/1705:25EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/9/2820:00PRNUSChemomab Therapeutics to Present Its CM-101 Clinical Program..
2023/8/2920:00PRNUSChemomab Therapeutics to Present at the H.C. Wainwright 25th..
2023/8/1421:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1421:00PRNUSChemomab Therapeutics Announces Second Quarter 2023..
2023/8/0819:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/0606:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0404:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/6/2820:00PRNUSChemomab Therapeutics Announces Publication in JCI Insight..
2023/6/2620:00PRNUSChemomab Therapeutics Presents Data Reinforcing the Clinical..
2023/6/2120:00PRNUSChemomab Therapeutics Reports Positive Data from Secondary..
2023/6/0520:00PRNUSChemomab Therapeutics Announces Executive Leadership Changes..
2023/6/0222:00PRNUSPatient Data Presented at 2023 EULAR Congress Highlights How..
2023/5/2420:00PRNUSChemomab Therapeutics to Participate in Upcoming Scientific..
2023/5/1119:00PRNUSChemomab Therapeutics Announces First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock